Embryonic stem cells Archivi - World Congress for Freedom of scientific research

The California Institute for Regenerative Medicine (CIRM) and the Medical University of Warsaw (MUW), a Polish state institution, entered a collaboration focused on stem cell research. The institutions are laying the groundwork for potential Polish-Californian research initiatives to advance stem cell therapies through collaborations among innovators in the field. CRIM and MUW said they believe

The Food and Drug Administration (FDA) approves a clinical trial using stem cell therapy on patients with spinal cord injury. The California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, is funding the trial. The Phase 1/2a clinical trial is designed to test the safety of this approach and to see if it has any

Researchers from Oregon Health & Science University show that, when pluripotent stem cells (iPSCs) or stem cells created using a process called somatic cell nuclear transfer (SCNT) are compared, the genomic and epigenomic landscapes of the resulting cell types differ with the genomes of stem cells created through SCNT matching those of embryonic stem cells

In January, Jordan passed a law to control research and therapy using human stem cells derived from embryos — the first such regulation in the Arab and Islamic region. Rana Dajani, who is associate professor of molecular cell biology at the Hashemite University in Zarqa, Jordan, and was part of the legislative initiative, writes Jordan has become

Research with human Embryonic Stem Cells (hESCs) faces challenges not only in labs but also in courts. During the summer of 2010, a US federal court barred the NIH from distributing money to fund research with hESCs. The case, Sherley v. Sebelius, revolved around the claim that the Dickey-Wicker Amendment, which prohibits using of federal